Literature DB >> 20349198

A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute.

Naoki Ohara1, Shoji Mihara, Hiroyuki Nihara, Narihiro Akimoto, Naoki Madokoro, Mikio Kawai, Hideki Noda, Michihiro Hide, Yasuhiro Matsumoto, Yoshimitsu Kuroyanagi.   

Abstract

In patients with burns, bone exposure accompanies serious problems which occasionally lead to amputation. We present a case of an 82-year-old woman who sustained 22% of total body surface area flame burns on her bilateral lower extremities with bone exposure. Despite fascial excision and mesh skin graft, muscles, bones, and tendons were widely exposed on her right leg. The wound was infected by methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. To promote wound healing, we applied an allogeneic cultured dermal substitute (CDS) to the wound surface once weekly, resulting in healthy granulation except for the exposed bone area of the right anterior tibia. We then shaved the cortex of the exposed bone surface until bone marrow bleeding, and grafted mesh skin in combination with CDS. Finally, all wounds healed without osteomyelitis. The use of CDS to treat deep burns exposing bone surface may expand reconstructive options for extremities that otherwise might have been amputated.

Entities:  

Mesh:

Year:  2010        PMID: 20349198     DOI: 10.1007/s10047-010-0499-7

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  25 in total

1.  Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute.

Authors:  Junko Nishimoto; Yasuyuki Amoh; Kenichi Tanabe; Nanako Niiyama; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  Eur J Dermatol       Date:  2007-06-01       Impact factor: 3.328

2.  An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.

Authors:  Toshio Hasegawa; Yasushi Suga; Masayuki Mizoguchi; Shigenori Muramatsu; Yuki Mizuno; Hideoki Ogawa; Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  J Dermatol       Date:  2005-09       Impact factor: 4.005

3.  A study of cytokines released from fibroblasts in cultured dermal substitute.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  Artif Organs       Date:  2005-10       Impact factor: 3.094

4.  Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth.

Authors:  D Gospodarowicz
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

5.  Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2003       Impact factor: 1.731

6.  Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS).

Authors:  Toshio Ohtani; Katsuyuki Okamoto; Chikako Kaminaka; Tomoh Kishi; Mikihisa Sakurane; Yuki Yamamoto; Koji Uede; Kentaro Kubo; Yoshimitsu Kuroyanagi; Fukumi Furukawa
Journal:  Eur J Dermatol       Date:  2004 May-Jun       Impact factor: 3.328

7.  Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.

Authors:  Akiko Hashimoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

8.  Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.

Authors:  Seiko Toyozawa; Yuki Yamamoto; Takeshi Nishide; Akiko Kishioka; Nobuo Kanazawa; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi; Fukumi Furukawa
Journal:  Dermatol Online J       Date:  2008-11-15

9.  Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  Artif Organs       Date:  2004-02       Impact factor: 3.094

10.  Relationship of transformation, cell density, and growth control to the cellular distribution of newly synthesized glycosaminoglycan.

Authors:  R H Cohn; J J Cassiman; M R Bernfield
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  3 in total

Review 1.  Journal of Artificial Organs 2010: the year in review.

Authors: 
Journal:  J Artif Organs       Date:  2011-03-16       Impact factor: 1.731

2.  Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study.

Authors:  Giorgio Pajardi; Vicenzo Rapisarda; Francesco Somalvico; Andrea Scotti; Giulia Lo Russo; Francesco Ciancio; Arturo Sgrò; Manuela Nebuloni; Raffaele Allevi; Maria L Torre; Emilio Trabucchi; Mario Marazzi
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

3.  Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers.

Authors:  Naoto Yamada; Eiju Uchinuma; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-12-03       Impact factor: 1.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.